Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness

NCT02843685 · clinicaltrials.gov ↗

COMPLETED

Status

12492

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Drotrecogin alfa activated

Sponsor

Boston Medical Center